Skip to main
IGC

IGC Stock Forecast & Price Target

IGC Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

The financial analyst highlights that IGC Pharma Inc.'s stock presents an attractive valuation with recent adjustments indicating substantial upside potential based on net present value (NPV) analyses. Notably, IGC-AD1 has demonstrated significant promise in preclinical studies, showing a statistically significant reduction in agitation among Alzheimer's patients compared to placebo, which may serve as a catalyst for positive market movement. The ongoing development of several investigational drug assets targeting Alzheimer's disease and related conditions further enhances the outlook for the company's future growth and profitability.

Bears say

IGC Pharma reported a net loss of $0.7 million, with earnings per share of $(0.01), which was slightly better than estimated but still indicates ongoing financial challenges. The company is projected to generate only $0.2 million in revenue, falling short of consensus estimates of $0.3 million, highlighting operational difficulties and potential market risks. Additionally, IGC Pharma faces numerous obstacles including liquidity risks, the uncertain success of its investigational drug candidates, and challenges related to regulatory approvals and commercialization, which contribute to a negative outlook on its stock performance.

IGC has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of India Globalization Capital and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About India Globalization Capital (IGC) Forecast

Analysts have given IGC a Strong Buy based on their latest research and market trends.

According to 1 analysts, IGC has a Strong Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

India Globalization Capital (IGC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.